Nuclear Science and Techniques

《核技术》(英文版) ISSN 1001-8042 CN 31-1559/TL     2019 Impact factor 1.556

Nuclear Science and Techniques ›› 2004, Vol. 15 ›› Issue (2): 111


125I-interleukin-8 radiolabelling and in vivo distribution

FAN Wo, QIAN Jian-Hua, ZHU Ran, NIN Ping, XU Yu-Jie, ZHANG Yi   

  1. School of Radiation Medicine and Public Health, Soochow University, Suzhou 215007
PDF ShareIt Export Citation
School of Radiation Medicine and Public Health, Soochow University, Suzhou . 125I-interleukin-8 radiolabelling and in vivo distribution.Nuclear Science and Techniques, 2004, 15(2): 111

Abstract: To study the radioiodinating condition of interleukin-8(IL-8) and observe its biodistribution in mice for understanding the possibility of its application in nuclear medicine, we labelled IL-8 with 125I using Bolton-Hunter reagent, and the distributions in mice at 5 min, 30 min, 1h, 6h and 24h after injection of 125I –IL-8 were measured. The blood clearance curve was obtained and fitted with the two-compartment model. The results showed that 125I-IL-8 was obtained with a labeling efficiency of 12.2% ±6.5% and a radiochemical purity of 91.4%±6.5%. Its specific activity was 14.8 kBq/μg IL-8. A fast phase half – life T1/2αof 0.32 h and a slow phase half – life T1/2β of 8.01 h were calculated from the blood clearance curve. The uptakes of radioactivities in kidneys and lung had the peaks of 85.87%ID /g and 16.17%ID /g at 30 min after intravenous injection, respectively. The uptakes in liver and spleen were 12.05%ID /g and 8.97%ID /g as the maximum at 5 min after injection. The clearance in blood and other organs was fast. Except for kidneys and lung, 125I –IL-8 was less than 1%ID/ g 24 h after administration. It is concluded that radioiodinated IL-8 is a promising radiopharmaceutical in nuclear medicine, especially for imaging infection. But to enhance the labeling efficiency of radioiodinated IL-8 and to decrease its in vivo deiodination are the subjects necessary to be further investigated.

Key words: Interleukin-8, 125I, Radiolabeling, Biodistribution